Skip to main content

C.R. Bard Wins First Bellwether Hernia Mesh Trial

C.R. Bard Wins First Bellwether Hernia Mesh Trial

C.R. Bard Wins First Bellwether Hernia Mesh Trial

Introduction

C.R. Bard has been awarded the first win in the Ventralight ST hernia mesh of Ohio, where the plaintiff accused that the company's product was defective and resulted in multiple injuries to him.

In 2015, the plaintiff got implanted the mesh to treat hernia, but soon he suffered pain and emotional distress due to the defective mesh products as per the allegations. Later, the plaintiff was required to undergo additional surgery to get the mesh removed, which was physically and mentally stressful for him.

As per the lawsuit, the plaintiff alleged that "ST" coating designed to "resorb" did not last for long as advertised by the company, which resulted in serious injuries. The lawsuit alleged the company of failing to inform the consumers about the design defects and risks associated with the products.

It is the first trial consolidated in the MDL formed in Ohio court in August 2018 against the company. On September 2, the court rejected the C.R. Bard’s pre-verdict motion, considering the evidence provided by the plaintiffs that highlight the dangers of the product to the patients.

U.S. District Judge Edmund A. Sargus, Jr. is overseeing all the product liability claims in the MDL formed in the Southern District of Ohio, where the company faces more than 8,000 lawsuits.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors

Categories: E-Cigarette: JUUL

As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.

A study published in Environmental Health Perspectives in…

Appeals Court Upholds $611M Roundup Verdict

Categories: Roundup

A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.

The case involved three plaintiffs from New…

Valsartan “Wave 2” Bellwether Trial Schedule Set by Court

Categories: Valsartan

As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.

This move comes in anticipation of the possibility that parties may…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!